Global Retirement Partners’s 10x Genomics TXG Stock Holding History

Global Retirement Partners’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$5.5K	Buy	337 +292	+649%	+$4.41K	﹤0.01%	3407
2025 Q3	$526	Hold	45	–	–	﹤0.01%	3638
2025 Q2	$521	Buy	+45	New	+$410	﹤0.01%	3573
2024 Q4	$57	Hold	4	–	–	﹤0.01%	3579
2024 Q3	$90	Sell	4 -1	-20%	-$21	﹤0.01%	3413
2024 Q2	$97	Sell	5 -17	-77%	-$445	﹤0.01%	3458
2024 Q1	$826	Sell	22 -150	-87%	-$6.59K	﹤0.01%	3023
2023 Q4	$7.66K	Sell	172 -97	-36%	-$4.22K	﹤0.01%	2168
2023 Q3	$10.7K	Buy	269 +12	+5%	+$624	﹤0.01%	1927
2023 Q2	$14.4K	Buy	257 +240	+1,412%	+$13K	﹤0.01%	1821
2023 Q1	$918	Buy	17 +5	+42%	+$233	﹤0.01%	2760
2022 Q4	$437	Hold	12	–	–	﹤0.01%	2791
2022 Q3	$0	Sell	12 -7	-37%	-$267	﹤0.01%	2986
2022 Q2	$1K	Buy	19 +15	+375%	+$778	﹤0.01%	2580
2022 Q1	$0	Buy	+4	New	+$350	﹤0.01%	2786

Other funds holding TXG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Global Retirement Partners's TXG Position: Q4 2025 in Review

Global Retirement Partners increased its 10x Genomics (TXG) stake by 649% in Q4 2025, buying an estimated $4.41K and bringing the position to 337 shares worth $5.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3407.

Global Retirement Partners first reported a position in TXG in Q1 2022 and has held it in 15 quarters since. The position peaked at $14.4K in Q2 2023. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

Global Retirement Partners held 337 shares of 10x Genomics worth $5.5K as of Q4 2025.
Global Retirement Partners bought 292 10x Genomics shares in Q4 2025, an estimated $4.41K.
10x Genomics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3407 holding.
Global Retirement Partners first reported a position in 10x Genomics in Q1 2022 and has held it in 15 quarters since.
Global Retirement Partners's 10x Genomics position peaked at $14.4K in Q2 2023.
322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.